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Abstract
Rationale, aims and objectives The illness management and recovery scale-clinician
version (IMRS-C) is a measure of outcomes thought to be important indicators of progress
for consumers participating in illness management and recovery (IMR). Prior research has
examined the psychometric properties of the IMRS-C; extant research supports certain
aspects of the scale’s reliability (test–retest) and validity (sensitivity to interventions).
Analyses based on Rasch provide certain advantages and have not been applied to the
IMRS-C.
Method This study used an archival IMRS database including responses regarding 697
participants with severe mental illness from a variety of community-based settings. Rasch
analyses were utilized to determine item functioning and utility of the IMRS-C.
Results Results of Rasch analyses using the IMRS-C as one unidimensional scale were
problematic. Analyses grouping items into three separate scales measuring recovery, man-
agement and biological vulnerability were more promising, but the third scale had other
limitations.
Conclusions Results suggest that the items included in the IMRS-C can form two
screeners, one for recovery and one for management; items regarding biological vulner-
ability were inadequate. The assessment could be supplemented by more refined measures
of coping/self-management and recovery constructs.
Introduction
The illness management and recovery scales (IMRSs) were
created in conjunction with the IMR Implementation Toolkit [1] to
provide a practical measure of consumer progress while partici-
pating in IMR. IMRS items target specific elements that the
model creators thought to be important indicators of illness
self-management. The IMRSs can be rated by the consumer as a
self-report measure, or by a clinician; both versions use the same
anchors. The IMRSs have been widely used in research [2–7] and
have provided the core of evidence supporting the effectiveness of
illness management and recovery [8].
Several analyses have examined the psychometric properties of
the IMRSs [9–12]; a key issue has been the dimensionality and
internal consistency of the scales. Most recently, Sklar and col-
leagues [12] noted the mixed results regarding internal consist-
ency, stating ‘the weaker estimates of Cronbach’s alpha reported to
date suggest the items may not be strongly interrelated’ (p. 222).
Consequently, they conducted a confirmatory factor analysis
(CFA) on data from 10 659 service users from a large U.S. county
in order to attempt to resolve this issue. Unfortunately, while the
CFA suggested a three-factor model fit better than a one-factor
model, the authors also indicated that Cronbach’s analysis sup-
ported the use of a one-factor model, leaving the issue of dimen-
sionality, and therefore appropriate use and scoring of the scale,
yet unsettled.
Rasch analysis (aka single-parameter item response analysis)
comprises an increasingly used set of methods to develop or refine
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measures. Rasch models address several deficiencies of traditional
psychometric approaches [13], including: the sample dependence
of person ability estimates; the lack of comparability of scores
obtained from different sets of items measuring the same con-
struct; the necessary completion of all items to allow comparisons
between respondents; the lack of interval-level raw scores; and the
concentration on group-level characteristics. In contrast, Rasch
models produce sample independent ability estimates. That is,
when the data fit the model, the estimation of the item difficulties
is not dependent on the distribution of the person abilities in
the calibration samples. Rasch models also produce interval-level
measures. In other words, the distance from 1 to 2 on the scale
is the same amount of increase in the construct (e.g. self-
management) as the increase from 10 to 11). In addition, Rasch
models validate items instead of a set of items, enabling the selec-
tion of few items that reliably differentiate ability across the latent
continuum.
The current study seeks to conduct a Rasch analysis on the
IMRS-clinician version (IMRS-C). By overcoming the difficulties
of traditional psychometric approaches, we hoped that Rasch
would provide more direct guidance on the adequacy of the items
in assessing the underlying construct, and provide guidance
as to whether scores can be used as an overall score (measuring
one dimension) or whether multiple theoretical dimensions are
reflected in the IMRS-C. Once dimensionality is clarified, we




Participants included 697 participants who completed the IMRSs
as part of one of four larger studies [6,7,14,15]. Participants were
adults with severe mental illness receiving outpatient mental
health treatment from participating community mental health
centres in Indiana. Participants included slightly more men
(n = 366, 52.7%) and were predominately white (n = 570. 83.2%);
the remainder of the sample included African American (n = 65,
9.5%), American Indian (n = 14, 2.0%), Asian/Pacific Islander
(n = 8, 1.2%), Hispanic (n = 11, 1.6%) or other (n = 17, 2.5%).
Most participants were single/never married (n = 355, 51.5%) or
divorced (n = 238, 36.6%), with the remainder single/living
together (n = 27, 4.1%) or married (n = 51, 7.8%). Educational
status was fairly low, with almost a third not having a high school
diploma or General Educational Development (GED, n = 184,
26.8%); the remainder had a high school diploma/GED (n = 239,
34.8%) or at least some college (n = 258, 37.6%). Self-reported
diagnoses included schizophrenia or schizoaffective disorder
(n = 228, 65.3%), bipolar disorder (n = 50, 14.3%), major depres-
sive disorder (n = 39, 11.2%), personality disorder (n = 3, 0.9%)
and other (n = 28, 8.3%). Participants were served by assertive
community treatment teams (n = 375, 53.8%) and other outpatient
mental health programs (n = 322, 46.2%).
Measures
The IMRS-C [16] was developed specifically to measure illness
self-management outcomes and is based on the stress-vulnerability
model [17,18]. The IMRS has fifteen 5-point items. Previous psy-
chometric analyses have found adequate internal consistency
(α > .70), test–retest reliability and convergent validity [9–12].
Procedures
Participants in each study provided informed consent and the
participants’ primary clinicians (predominately case managers)
completed the IMRS-C and returned it to the research team. All
study procedures were approved by the university’s Institutional
Review Board.
Analysis
We first calculated the mean, range and standard deviation for the
IMRS using SPSS 19.0. For the remaining analyses, missing data
were imputed using the mode of the variable. Mode imputation was
chosen over more sophisticated but less accessible methods to
enable the computation of a total score by administrators and
clinicians without access to advanced statistical software. We also
recognize that imputing the item mode would result in conservative,
rather than inflated ability estimates. We next used Rasch analysis
(i.e. a 1-parameter logistic item response analysis) as implemented
in WINSTEPS version 3.80.0. We first analysed the full IMRS scale
and, as described below, analysed each component ‘scale’ that
reflects an underlying dimension separately. For the full scale,
dimensionality was assessed by analysing the residual variance
with eigenvalues greater than 2.0 indicating the presence of a
secondary dimension. Infit and outfit statistics were examined with
values less than .6 or greater than 1.4 indicating poor fit. Item local
independence was examined, with items sharing 15% common
variance outside the main dimension considered to be locally
dependent and therefore problematic for a single dimension.
Subsequently, the three separate scales were examined in terms
of dimensionality as described above. Additionally, targeting was
calculated as the difference between average domain measures
and item calibrations, with zero being ‘perfect targeting’, .50–.99
‘slight mistargeting’, and ≥1.00 ‘substantial mistargeting’ [19].
The number of distinct strata was calculated as (4G + 1)/3, where
G is the separation index. Item probability curves were examined
to ensure that all anchors were most probable at some point and
that all items met the monotonicity assumption. Point-biserial
correlations were used to examine the relationship between the
item and the main dimension.
Results
Descriptive statistics
Descriptive statistics for item and scale scores can be seen in
Table 1. Means ranged from 2.0 to 4.6. Several items had a
restricted range due to ceiling or floor effects. The per cent of
respondents at floor (i.e. responding ‘1’) ranged across items from
less than 1 to 44% and the percent at ceiling (i.e. responding ‘5’)
ranged across items from 5 to 82%.
Rasch analysis: one-scale approach
We first conducted a Rasch analysis with all items loaded onto
one scale. This approach produced several problematic results.
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Analyses indicated that one secondary component in the data
exceeded the criterion value of 2.0. It contrasted items 6, 7, 9, 10
and 11 with the other items. This indicates these items have some-
thing in common that separate them from the assumed single
dimension of IMR improvement. Similarly, several items lacked
local independence: 2 and 8, 6 and 7, 7 and 11, 9 and 10, 14 and
15, indicating these items have more in common with each other
than just the main dimension of IMR improvement. Finally, items
5, 6, 7 and 13 failed to demonstrate monotonically increasing (i.e.
never decreasing) average patient ability measures across response
options 1–5 on the item response structure. This occurrence is
particularly concerning because it indicates the average participant
answering a ‘3’ on a given item is lower on IMR improvement than
the participants answering a ‘2’ on that item. We therefore con-
cluded that a one-scale approach was inappropriate.
Rasch analyses: three-scale approach
We next conducted a series of three Rasch analyses in which we
created three scales composed of the items loading on each of the
three factors identified by Sklar and colleagues [12] (see Table 3).
We adopted this course because items composing the second
dimension in our data were the same as the second factor identified
by Sklar and colleagues [12]. Moreover, pairs of items that shared
common variance in our previous Rasch analysis always loaded
onto the same of Sklar and colleagues’ [12] factors.
Scale 1 – ‘Recovery’
The first scale (assessing a ‘recovery’ dimension) was composed
of items 1, 2, 4, 8, 12 (e.g. ‘As far as Progress towards personal
goals: In the past 3 months, I have come up with . . .’). Results
indicated only one dimension was present for these items: no
second dimension was identified (secondary dimension < 2.0
eigenvalue units), no items were locally dependent (residual cor-
relations >.3), and infit and outfit statistics for items were all
within acceptable parameters (1.0 ± .4). Internal consistency was
less than acceptable (α = .67). Scale logit scores and raw scores
were strongly correlated (.98).
Targeting
Difference in person means was .13, indicating the ‘average’
person and the ‘average’ item were at about the same place on the
recovery dimension.
Strata
The recovery scale produced 2.19 statistically distinguishable
performance levels; this means that for a given person, the scale
only reliably placed the person as either ‘high’ or ‘low’ on recov-
ery. There is too much ‘noise’ to make a more fine-grained deter-
mination. As with all scales, the reliability of the scale differs
depending on where in the distribution a person scores; however,
we can use the scale midpoint (summed scale score of 15) as an
example [20]. For this point in the scale, the 95% confidence
interval was ± .92 logits; therefore, a raw score >20 or better was
reliably better (95% confidence interval) than the midpoint and a
score <10 was reliably lower than midpoint.
Item functioning
Rasch provides several ways to examine how well each item is
functioning within the model. Table 2 displays item difficulty for
each item, which provides an indicator of where on the recovery
dimension each item generally falls. Results indicated items gen-
erally clustered in the middle of the recovery continuum; that is, no
items received high scores from even people low on the recovery
continuum and no items received low scores from only respond-
ents high on the recovery continuum. Point-measure correlations
indicate the degree to which responses to a particular item corre-
late with the recovery dimension. Results indicated items are mod-
erately to strongly related to the dimension. We examined item
Table 1 Descriptive statistics for illness






Overall mean 3.19 0.56 – –
1 Progress towards goals 2.73 1.06 74 (14.8%) 23 (4.6%)
2 Knowledge 2.97 1.07 51 (10.2%) 29 (5.8%)
3 Family/friend involvement in treatment 2.88 1.26 92 (18.4%) 48 (9.6%)
4 Contact with people outside of family 3.31 1.24 27 (5.4%) 124 (24.8%)
5 Time in structured roles 1.95 1.23 268 (53.6%) 24 (4.8%)
6 Symptom distress 2.67 0.94 61 (12.2%) 6 (1.2%)
7 Impairment of functioning 2.60 0.95 69 (13.8%) 2 (0.4%)
8 Relapse prevention planning 2.58 1.12 93 (18.6%) 16 (3.2%)
9 Relapse of symptoms 3.24 1.46 84 (17.0%) 141 (28.5%)
10 Psychiatric hospitalizations 4.26 1.18 25 (5.0%) 316 (63.7%)
11 Coping 2.99 0.95 32 (6.4%) 31 (6.2%)
12 Involvement with self-help activities 2.99 1.33 56 (11.2%) 85 (17.0%)
13 Using medication effectively 4.42 0.87 11 (2.2%) 291 (58.6%)
14 Alcohol use 4.57 0.98 10 (2.9%) 274 (79.2%)
15 Drug use 4.60 0.97 11 (3.2%) 286 (82.4%)
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probability curves to see that each item anchor is most probable
at some point on the ability continuum; results were generally
good. Only items 4 (anchor 4) and 12 (anchor 3) were never most
probable. Importantly, unlike the single scale analyses, all items
demonstrated monotonically increasing (i.e. never decreasing)
average patient ability measures across response options 1–5 on
the item response structure.
Scale 2 – ‘Management’
The second scale (assessing a ‘management’ dimension) was
composed of items 6, 7, 9, 10, 11 (e.g. ‘In regards to Symptom
of distress: How much do your symptoms bother you?). We
included item 10 even though Sklar and colleagues [12] did
not because it was consistent with the second dimension identi-
fied in our initial Rasch analysis. In addition, it made conceptual
sense that hospitalization would be related to management of
one’s illness. Regarding dimensionality of the management
scale, a potential second dimension was identified with an
eigenvalue exactly on the threshold (2.0); however, no items
were locally dependent. Infit statistics for items were all within
acceptable parameters (± .4); however, item 9 exceeded the
parameter for outfit. Internal consistency was good for this scale
(α = .80).
Targeting
Difference in person means was .1, indicating the ‘average’ person
and the ‘average’ item were at about the same place on the self-
management dimension.
Table 2 Item fit and point-measure correlations for the total scale
Item
Item
difficulty Count Infit Outfit
Point-measure
correlations
1 Progress towards goals .51 499 .96 .96 .53
2 Knowledge .29 501 .89 .89 .57
3 Family/friend involvement in treatment .33 499 1.36 1.41 .31
4 Contact with people outside of family −.33 499 1.19 1.24 .41
5 Time in structured roles 1.02 500 1.12 1.19 .48
6 Symptom distress .83 499 .93 .93 .51
7 Impairment of functioning 1.16 500 .81 .80 .62
8 Relapse prevention planning .70 499 .84 .83 .62
9 Relapse of symptoms −.07 495 1.00 1.00 .57
10 Psychiatric hospitalizations −.84 496 1.14 1.33 .40
11 Coping .15 500 .69 .69 .72
12 Involvement with self-help activities .03 500 1.16 1.23 .47
13 Using medication effectively −1.08 497 1.00 1.16 .40
14 Alcohol use −1.55 346 1.05 1.03 .38
15 Drug use −1.15 347 .94 .80 .43
Table 3 Item fit and point-measure correlations for three dimensions
Item
Item




1 Progress towards goals .33 499 1.01 1.02 .63
2 Knowledge .03 501 .87 .85 .69
4 Contact with people outside of family −.69 499 1.28 1.34 .56
8 Relapse prevention planning .56 499 .77 .75 .73
12 Involvement with self-help activities −.23 500 1.08 1.05 .65
Management scale items
6 Symptom distress 1.48 499 .94 .93 .74
7 Impairment of functioning 1.06 500 .86 .83 .77
9 Relapse of symptoms −.53 495 .90 1.69 .77
10 Psychiatric hospitalizations −2.00 496 1.40 1.30 .58
11 Coping −.01 500 1.01 1.01 .73
Biology scale items
13 Using medication effectively .08 497 1.19 1.08 .84
14 Alcohol use −.04 345 .93 .77 .72
15 Drug use −.04 347 .87 .52 .72
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Strata
The management scale produced 2.81 statistically distinguishable
performance levels; again, the scale only reliably placed the
person as either ‘high’ or ‘low’ on management. For this scale, the
95% confidence interval was ± .92 logits; therefore, a score of 18
or better was reliably better (95% confidence interval) than an
average score of 15, and a score of 12 or lower was reliably lower
than average.
Item functioning
As shown in Table 2, items on the management scale covered a
wide range of the continuum, with some items (e.g. impairment in
functioning) very difficult and others (e.g. psychiatric hospitaliza-
tion) very easy. Point-measure correlations indicated moderate
to strong correlations with the main dimension. Item probability
curves indicated that all anchors were most probable at some point
and that all items met the monotonicity assumption. In general,
results indicated that items were functioning well within the
model.
Scale 3 – ‘Biology’
Results for the three ‘biology’ items (13, 14, 15; e.g. ‘As far as
Using Medication Effectively: How often do you take your medi-
cation as prescribed?’) were less encouraging. Regarding dimen-
sionality of this scale, no second dimension accounting for greater
than 2.0 eigenvalue units was identified; however, all items were
locally dependent, with correlated variance outside the model
exceeding 15%. Infit/outfit statistics were acceptable, with no
items with values outside of 1.0 ± .4.
Targeting
The difference in person means was 3.03, indicating the ‘average’
person was over 3 logit scores above the ‘average’ item on the
biology dimension. In other words, participants generally endorsed
the highest anchors on all items (see also Table 1 regarding ceiling
effects).
Strata
Less than one (.68) strata could be identified; the biology scale was
not reliable enough to categorize people into distinct categories.
Item functioning
Point-biserial correlations indicated moderate to strong correla-
tions with the main dimension. Item probability curves indicated
that for item 13, a response of ‘3’ was never most probable. For
item 14, responses 2 and 4 were most probable, but at a very small
range of the continuum. For item 15, responses 2 and 4 were never
most probable. All items met the monotonicity assumption.
Discussion
Our results indicate the IMRS-C is most appropriately modelled
using three conceptual dimensions: recovery, management and
biology. When modelling the scale as three scales, there is little
advantage to the use of a logit transformation or anchor modifica-
tions – raw scores are adequately reliable. However, although three
dimensions were identified, the items assessing the third dimen-
sion did not perform well enough to be considered a scale. In
addition, the management and recovery scales are useful as rough
screeners, but cannot be reliably used for more fine-grained meas-
urement due to the relatively large error around ability estimates.
Our results join a growing body of literature that demonstrates
the IMRS-C measures more than one construct [11,12]. The three
dimensions indicated by our results are consistent with the stress
vulnerability model of mental illness [21]. People strive to learn
and implement strategies to manage their illnesses. In addition,
other factors affect biological vulnerabilities to mental disability
(i.e. substances and medication). Self-management strategies and
management of biological factors work together to affect changes
in community functioning, role functioning and other indicators of
‘recovery’. To combine the IMRS into one total score is to ignore
this conceptual distinction and lose meaningful information about
the person being measured.
The IMRS was constructed with each meaningful element rep-
resented by one item. This decision was made with practicality in
mind, and the resulting scale can be administered with minimal
burden to busy clinical staff. The trade-off to this approach is
reliability and sensitivity. Based on our analyses, the management
and recovery scales derived from the IMRS-C represent acceptable
and usable screeners for their respective constructs. For each, only
about two distinct strata, (i.e. two groups of ‘high’ or ‘low’) could
be identified reliably. Clinical implications from our findings indi-
cate that the scales could be used to triage consumers into appro-
priate services. For instance, at intake the management scale
may quickly assess people who may benefit from basic self-
management education. It would be inappropriate, though, to use
the management scale to determine incremental change after an
intervention. The implications for research are even more striking.
The IMRS-C overestimates the amount of variability or ‘noise’,
thereby reducing power in statistical analyses. Previous research
showing positive impacts on the IMRS-C has likely greatly under-
estimated the true effect of IMR. Subsequent research using
more sensitive measures could better estimate effect sizes and
would require much smaller samples to demonstrate statistical
significance.
The items tapping biological vulnerability are conceptually
consistent with the stress vulnerability model of mental health;
however, these items did not function well as a scale in our analy-
ses. All the items are ‘too easy’, reflected by the ceiling effects for
the items, which have been found in all studies reporting item-level
averages for the IMRS-C [9,10,12]. Three explanations could
plausibly explain this ceiling effect. First, items may need to be
added to capture people higher on the ‘biology’ continuum (i.e.
people with less impairment from drugs/alcohol and who adhere
more fully to medication regiments). This suggestion makes little
sense, though, because a response of ‘5’ on all three items indicates
a complete lack of impairment due to alcohol/drugs and complete
adherence to medication. In other words, these responses appear
to be the upper conceptual limit. The second explanation is that
participants in this and other psychometric studies of the IMRS-C
generally do not suffer from impairment in these areas. This expla-
nation seems implausible given the prevalence of substance use
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and medication non-adherence in this population [22–26]. The
final explanation is that clinicians underestimate consumers’ sub-
stance use and medication non-adherence. Given that clients often
under-report substance abuse or medication non-adherence
[27,28], it would not be surprising if clinicians also under-report
actual use. With the availability of numerous psychometrically
sound measures regarding substance use (e.g. the decisional
balance scale [29]; AUDIT-C [30]) and medication adherence
(MARS [31]), we suggest that the biology items be omitted from
the IMRS-C and established screeners be used in their place.
This study utilized a relatively large sample from various ser-
vice settings to investigate the item functioning and utility of the
IMRS-C. However, results are limited in that the sample was
primarily white with lower levels of education. Results suggest that
the items currently composing IMRS-C should be disaggregated.
Two scales – management and recovery screeners – can be formed
from the extant items. Biological vulnerability, although conceptu-
ally important, is not reliably measured by the intended items. The
assessment could be supplemented in practice by more refined
measures of coping/self-management and recovery constructs.
Acknowledgements
This study was funded in part by VA HSR&D: IAC 05-254-3
Illness Management and Recovery for Veterans with Severe
Mental Illness, by grant H133G030106 from the National Institute
of Disability and Rehabilitation Research, by grant SM56140-01
from the Substance Abuse and Mental Health Services Adminis-
tration, and a contract with the Division of Mental Health and
Addiction, Indiana Family and Social Services Administration.
Dr McGuire was supported by VA RR&D D0712-W CDA, Goal
Setting in Psychiatric Rehabilitation, and the Center for Health
Information and Communication, Department of Veterans Affairs,
Veterans Health Administration, Health Services Research and
Development Service CIN 13-416. The views expressed in this
article are those of the authors and do not necessarily represent the
official views of the funders.
References
1. Gingerich, S. & Mueser, K. T. (2002) Illness Management and Recov-
ery Implementation Resource Kit. Rockville, MD: Center for Mental
Health Services, Substance Abuse and Mental Health Services Admin-
istration.
2. Bullock, W. A., O’Rourke, M., Breedlove, A., Farrer, E. & Smith, M.
K. (2007) Effectiveness of the illness management and recovery
program in promoting recovery: preliminary results. New Research in
Mental Health, 17, 282–291.
3. Hasson-Ohayon, I., Roe, D. & Kravetz, S. (2007) A randomized
controlled trial of the effectiveness of the illness management and
recovery program. Psychiatric Services: A Journal of the American
Psychiatric Association, 58 (11), 1461–1466.
4. Färdig, R., Lewander, T., Melin, L., Folke, F. & Fredriksson, A. (2011)
A randomized controlled trial of the illness management and recovery
program for persons with schizophrenia. Psychiatric Services: A
Journal of the American Psychiatric Association, 62 (6), 606–
612.
5. Levitt, A. J., Mueser, K. T., DeGenova, J., Lorenzo, J., Bradford-Watt,
D., Barbosa, A., Karlin, M. & Chernick, M. (2009) Randomized
controlled trial of illness management and recovery in multiple-unit
supportive housing. Psychiatric Services: A Journal of the American
Psychiatric Association, 60 (12), 1629–1636.
6. Salyers, M. P., Godfrey, J. L., McGuire, A. B., Gearhart, T., Rollins, A.
L. & Boyle, C. (2009) Implementing the illness management and
recovery program for consumers with severe mental illness. Psychiat-
ric Services: A Journal of the American Psychiatric Association, 60
(4), 483–490.
7. Salyers, M. P., McGuire, A. B., Rollins, A. L., Bond, G. R., Mueser,
K. T. & Macy, V. R. (2010) Integrating assertive community treatment
and illness management and recovery for consumers with severe
mental illness. Community Mental Health Journal, 46 (4), 319–329.
8. McGuire, A. B., Kukla, M., Green, A., Gilbride, D., Mueser, K. T. &
Salyers, M. P. (2014) Illness management and recovery: a review of
the literature. Psychiatric Services: A Journal of the American Psy-
chiatric Association, 65, 171–179.
9. Salyers, M. P., Godfrey, J. L., Mueser, K. T. & Labriola, S. (2007)
Measuring illness management outcomes: a psychometric study of
clinician and consumer rating scales for illness self management and
recovery. Community Mental Health Journal, 43 (5), 459–480.
10. Färdig, R., Lewander, T., Fredriksson, A. & Melin, L. (2011) Evalu-
ation of the illness management and recovery scale in schizophrenia
and schizoaffective disorder. Schizophrenia Research, 132, 157–164.
11. Hasson-Ohayon, I., Roe, D. & Kravetz, S. (2008) The psychometric
properties of the Illness Management and Recovery scale: client and
clinician versions. Psychiatry Research, 160 (2), 228–235.
12. Sklar, M., Sarkin, A., Gilmer, T. & Groessl, E. (2012) The psycho-
metric properties of the Illness Management and Recovery scale in a
large American public mental health system. Psychiatry Research, 199
(3), 220–227.
13. Shultz, K. S. & Whitney, D. J. (2005) Measurement Theory in Action:
Case Studies and Exercises. Thousand Oaks, CA: Sage Publications,
Inc.
14. Salyers, M. P., Stull, L., Rollins, A. & Hopper, K. (2011) The work of
recovery on two assertive community treatment teams. Administration
and Policy in Mental Health and Mental Health Services Research, 38
(3), 169–180.
15. Salyers, M. P., Matthias, M. S., Sidenbender, S. & Green, A. (2013)
Patient activation in schizophrenia: insights from stories of illness and
recovery. Administration and Policy in Mental Health and Mental
Health Services Research, 40 (5), 419–427.
16. Mueser, K. T., Gingerich, S., Salyers, M. P., McGuire, A. B., Reyes,
R. U. & Cunningham, H. (2004) The Illness Management and Recov-
ery Scale (IMR). Lebanon, NH: New Hampshire-Dartmouth Psychi-
atric Research Center.
17. Liberman, R. P., Mueser, K. T., Wallace, C. J., Jacobs, H. E., Eckman,
T. & Massel, H. K. (1986) Training skills in the psychiatrically dis-
abled: learning coping and competence. Schizophrenia Bulletin, 12,
631–647.
18. Zubin, J. & Spring, B. (1977) Vulnerability: a new view of schizo-
phrenia. Journal of Abnormal Psychology, 86, 103–126.
19. Duncan, P. W., Bode, R. K., Min Lai, S. & Perera, S. (2003) Rasch
analysis of a new stroke-specific outcome scale: the Stroke Impact
Scale. Archives of Physical Medicine and Rehabilitation, 84 (7), 950–
963.
20. Jette, A. M. & Haley, S. M. (2005) Contemporary measurement
techniques for rehabilitation outcomes assessment. Journal of Reha-
bilitation Medicine, 37 (6), 339–345.
21. Mueser, K. T., Meyer, P. S., Penn, D. L., Clancy, R., Clancy, D. M. &
Salyers, M. P. (2006) The Illness Management and Recovery program:
rationale, development, and preliminary findings. Schizophrenia
Bulletin, 32 (1), 32–43.
22. Adams, J. & Scott, J. (2000) Predicting medication adherence in
severe mental disorders. Acta Psychiatrica Scandinavica, 101 (2),
119–124.
Rasch analysis of IMRS-C A.B. McGuire et al.
Published 2014. This article is a U.S. Government work and is in the public domain in the USA.388
23. Pratt, S. I., Mueser, K. T., Driscoll, M., Wolfe, R. & Bartels, S. J.
(2006) Medication nonadherence in older people with serious mental
illness: prevalence and correlates. Psychiatric Rehabilitation Journal,
29 (4), 299–310.
24. Regier, D. A., Farmer, M. E., Rae, D. S., Lock, B. Z., Keith, S. J., Judd,
L. L. & Goodwin, F. K. (1990) Comorbidity of mental disorders with
alcohol and other drug abuse: results from the Epidemiologic Catch-
ment Area (ECA) study. Journal of the American Medical Association,
264 (19), 2511–2518.
25. Mueser, K. T., Yarnold, P. R., Levinson, D. F., Singh, H., Bellack,
A. S., Kee, K., Morrison, R. L. & Yadalam, K. G. (1990) Prevalence of
substance abuse in schizophrenia: demographic and clinical correlates.
Schizophrenia Bulletin, 16 (1), 31–56.
26. Mueser, K. T., Yarnold, P. R., Rosenberg, S. D., Swett, C. Jr, Miles,
K. M. & Hill, D. (2000) Substance use disorder in hospitalized
severely mentally ill psychiatric patients. Schizophrenia Bulletin,
26 (1), 179–192.
27. Garber, M. C., Nau, D. P., Erickson, S. R., Aikens, J. E. & Lawrence,
J. B. (2004) The concordance of self-report with other measures of
medication adherence: a summary of the literature. Medical Care, 42
(7), 649–652.
28. Johnson, T. & Fendrich, M. (2005) Modeling sources of self-report
bias in a survey of drug use epidemiology. Annals of Epidemiology, 15
(5), 381–389.
29. Carey, K. B., Maisto, S. A., Carey, M. P. & Purnine, D. M. (2001)
Measuring readiness-to-change substance misuse among psychiatric
outpatients: I. Reliability and validity of self-report measures. Journal
of Studies on Alcohol, 62 (1), 79–88.
30. Bush, K., Kivlahan, D. R., McDonell, M. B., Fihn, S. D. & Bradley,
K. A. (1998) The AUDIT alcohol consumption questions (AUDIT-C):
an effective brief screening test for problem drinking. Archives of
Internal Medicine, 158 (16), 1789–1795.
31. Fialko, L., Garety, P. A., Kuipers, E., Dunn, G., Bebbington, P. E.,
Fowler, D. & Freeman, D. (2008) A large-scale validation study
of the Medication Adherence Rating Scale (MARS). Schizophrenia
Research, 100 (1), 53–59.
A.B. McGuire et al. Rasch analysis of IMRS-C
Published 2014. This article is a U.S. Government work and is in the public domain in the USA. 389
